A fascinating study out of the National Cancer Institute has significant implications for men at risk for prostate cancer and men with enlarged prostates--for most men, really. But the study invites possible overinterpretation. Let's parse it carefully.
Bottom line first
Finasteride, a drug used to treat benign prostatic hyperplasia (non-cancerous prostate enlargement, also known as BPH) has previously been linked to a reduction in prostate size and lower risk of prostate cancer. This new...
